Omsav Pharma Research Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Omsav Pharma Research Private Limited

Omsav Pharma Research Private Limited, a active private limited company, was established on 23 February 2016 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH2016PTC339817. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.22 Cr.

It upholds a compliant status. Employing 39 professional, Its leadership includes Om Dutt Tyagi (Managing Director), Tushar Srivastava Kumar (Director), Kewal Kundanlal Handa (Director). Past directors included Yogendra Kumar Chauhan, Om Dutt Tyagi, Tushar Srivastava Kumar. It holds ₹7.81 Cr open charges and ₹2.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 74/Ii,Ccrossroad,Oppgateno.2(Seepz)Midc,Andheri-(East),Mumbai-400093, Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2016PTC339817

  • Registration Number

    339817

  • Incorporation Date

    23 February 2016

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹1.22 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 1.22 Cr
  • Company Age 9 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 7.81 Cr
  • Satisfied Charges ₹ 2.25 Cr
  • Revenue Growth **** -2.32%
  • Profit Growth **** 13.38%
  • Ebitda **** 282.84%
  • Net Worth 23.20%
  • Total Assets **** 14.97%
Company report

Omsav Pharma Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Omsav Pharma Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Omsav Pharma Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Om Dutt Tyagi Managing Director 23 Feb 2016 Current
Tushar Srivastava Kumar Director 30 Sep 2022 Current
Kewal Kundanlal Handa Director 24 Mar 2017 Current
Savita Tyagi Director 30 Sep 2022 Current
Ranchodlal Keshavlal Shah Director 07 Apr 2016 Current
Himadri Sen Director 12 Dec 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Apr 2016 Past
Pramod Abcsdd Director 01 Aug 2019 Past
Pramod Abcsdd Director 12 Sep 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Director - Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Omsav Pharma Research.

Omsav Pharma Research Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.32% decrease. The company also saw a substantial improvement in profitability, with a 13.38% increase in profit. The company's net worth Soared by an impressive increase of 23.2%.

Omsav Pharma Research revenue growth over time
Omsav Pharma Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.32%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.19%
*******
*******
*******
*******
Total Assets
*******
 14.97%
*******
*******
*******
*******
Profit or Loss
*******
 13.38%
*******
*******
*******
*******
Net Worth
*******
 23.20%
*******
*******
*******
*******
EBITDA
*******
 282.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Omsav Pharma Research?

In 2023, Omsav Pharma Research had a public holding of 2.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹78,100,000.00

Satisfied Charges

₹22,475,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 7.81 Cr
Latest Charge Details
Date Lender Amount Status
25 Feb 2021 Bank Of India ₹7.81 Cr Open
30 Aug 2018 Yes Bank Limited ₹2.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Omsav Pharma Research?

Omsav Pharma Research has a workforce of 39 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Omsav Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omsav Pharma Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Omsav Pharma Research
Recent Activity within the Organization
  • Annual General Meeting

    Omsav Pharma Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Omsav Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    Tushar Srivastava Kumar was appointed as a Director was appointed as a Director on 30 Sep 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Savita Tyagi was appointed as a Director was appointed as a Director on 30 Sep 2022 & has been associated with this company since 3 years 4 months . was completed.

  • Charges

    A charge with Bank Of India of Rs. 7.81 Cr registered on 25 Feb 2021 with Charge ID 100425943 was modified on 14 Sep 2022. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 30 Aug 2018 via Charge ID 100212847 with Yes Bank Limited was fully satisfied on 30 Mar 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Omsav Pharma Research Private Limited?

The CIN of Omsav Pharma Research Private Limited is U24230MH2016PTC339817.

Where is Omsav Pharma Research Private Limited headquartered?

Omsav Pharma Research Private Limited is headquartered at 74/Ii,Ccrossroad,Oppgateno.2(Seepz)Midc,Andheri-(East),Mumbai-400093, Mumbai, Maharashtra, 400093.

When was Omsav Pharma Research Private Limited incorporated?

Omsav Pharma Research Private Limited was incorporated on 23 February 2016.

Who are the current directors of Omsav Pharma Research Private Limited?

The current directors of Omsav Pharma Research Private Limited are

What is the primary industry of Omsav Pharma Research Private Limited?

The primary industry of Omsav Pharma Research Private Limited is Manufacturing.

Is Omsav Pharma Research Private Limited a listed company?

Omsav Pharma Research Private Limited is unlisted.

What is the capital structure of Omsav Pharma Research Private Limited?

The authorized capital of Omsav Pharma Research Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.22 Cr.

What is the compliance status of Omsav Pharma Research Private Limited?

The compliance status of Omsav Pharma Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available